Clinical trial

Efficacy and Safety of Fibrin Sealant Vapor Heated Solvent/Detergent Treated (FS…

NCT00161980 · Baxter Healthcare Corporation, Industry · Completed

Key facts

NCT number NCT00161980
Title Efficacy and Safety of Fibrin Sealant Vapor Heated Solvent/Detergent Treated (FS VH S/D) for Reduction of Lymphatic Leakage by Sealing Axillary Lymph Node Dissection Sites
Official title A Randomized and Controlled Clinical Study to Evaluate the Efficacy and Safety of Fibrin Sealant VH S/D (FS VH S/D) in Reduction of Lymphatic Leakage by Sealing Axillary Lymph Node Dissection Sites
Lead sponsor Baxter Healthcare Corporation, Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Breast Cancer, Lumpectomy, Mastectomy Plus Axillary Lymph Node Dissection, Lymphatic Leakage
Intervention type Drug, Procedure
Interventions Fibrin Sealant VH S/D, Surgical intervention alone without Fibrin Sealant VH S/D application
Start date Jun 1, 2001
Completion Dec 1, 2002
First posted Sep 13, 2005
Last update posted Oct 23, 2006
Countries Austria, France, Germany, Italy

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies